Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.

Ross, D D; Yang, W; Abruzzo, L V; Dalton, W S; Schneider, E; Lage, H; Dietel, M; Greenberger, L; Cole, S P; Doyle, L A

Ross, D D; Yang, W; Abruzzo, L V; Dalton, W S; Schneider, E; Lage, H; Dietel, M; Greenberger, L; Cole, S P; Doyle, L A.

Affiliation

Ross DD; University of Maryland Greenebaum Cancer Center, Department of Medicine, University of Maryland School of Medicine, and Baltimore Veterans Medical Center, 21201, USA. DROSS@umcc01.umcc.ab.umd.edu

J Natl Cancer Inst ; 91(5): 429-33, 1999 Mar 03.

Article in En | MEDLINE | ID: mdl-10070941

Subject(s)

Antineoplastic Agents/pharmacology; Breast Neoplasms/drug therapy; Breast Neoplasms/metabolism; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Mitoxantrone/pharmacology; Neoplasm Proteins/biosynthesis; Blotting, Northern; Blotting, Southern; Breast Neoplasms/genetics; Colonic Neoplasms/drug therapy; Colonic Neoplasms/metabolism; Drug Resistance, Multiple/genetics; Drug Resistance, Neoplasm/genetics; Fibrosarcoma/drug therapy; Fibrosarcoma/metabolism; Humans; Multiple Myeloma/drug therapy; Multiple Myeloma/metabolism; Neoplasm Proteins/genetics; RNA, Messenger/analysis; RNA, Neoplasm/analysis; Stomach Neoplasms/drug therapy; Stomach Neoplasms/metabolism; Tumor Cells, Cultured; Up-Regulation

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Gene Expression Regulation, Neoplastic / Mitoxantrone / Drug Resistance, Multiple / Drug Resistance, Neoplasm / Neoplasm Proteins / Antineoplastic Agents Type of study: Risk_factors_studies Limits: Humans Language: En Journal: J Natl Cancer Inst Year: 1999 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links